Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Bullboard Posts
Comment by moneystarvedon Feb 05, 2014 11:52am
117 Views
Post# 22174761

RE:RE:RE:RE:RE:RE:I'm Positive on ICO

RE:RE:RE:RE:RE:RE:I'm Positive on ICOYou forgot a few other positives:
-JDRF partnered with ICO to help prove out iCo-007.  The last drug they partnered with is now worth how much?
-Phase 1 showed ICO was safe...but ALSO actually had some efficacy results.
-the safety and results occured on those that were willing to "test" a needle in the eye, which are typically the worst of the worst, which have tried all other options.
-einsider can/will have zero actual effect on the stock (ie. trolls dont matter).  What will is really just two things now, US movement closer to results, AND/OR results.

As always.....if einsider feels it is terrible, short it (good luck).
if you are like me, and feel this is a great time to buy.... buy it.

Only time will truly tell.  I have put my money where my mouth is. I doubt einsider has (nor the way his posts are written, probably has any period(.
imo
gl
Bullboard Posts